Skip to content

Clinical trials

Phase 1/2 Leukemia, Biphenotypic, Acute trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Biphenotypic, Acute Phase: Phase 1/2 Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20031
20051
20061
20071
20091
20141
20163
20171
20194
20201
20212
20223
20231
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting11
Active, not recruiting2
Withdrawn2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center7
M.D. Anderson Cancer Center3
Children's Oncology Group2
Memorial Sloan Kettering Cancer Center2
University of Washington2
AVM Biotechnology Inc1
Asan Medical Center1
Cancer Treatment Centers of America1
Kura Oncology, Inc.1
National Cancer Institute (NCI)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Biphenotypic, Acute31
Leukemia, Myeloid, Acute27
Precursor Cell Lymphoblastic Leukemia-Lymphoma20
Leukemia15
Lymphoma11
Burkitt Lymphoma10
Leukemia, Lymphocytic, Chronic, B-Cell10
Leukemia, Myelomonocytic, Chronic10
Lymphoma, Follicular10
Lymphoma, Large B-Cell, Diffuse10

Trials

Showing 26 to 31 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.